Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4846221
Max Phase: Preclinical
Molecular Formula: C21H15ClFN3O3S
Molecular Weight: 443.89
Molecule Type: Unknown
Associated Items:
ID: ALA4846221
Max Phase: Preclinical
Molecular Formula: C21H15ClFN3O3S
Molecular Weight: 443.89
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CS(=O)(=O)Nc1cccc(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F
Standard InChI: InChI=1S/C21H15ClFN3O3S/c1-30(28,29)26-18-4-2-3-15(19(18)23)20(27)17-11-25-21-16(17)9-13(10-24-21)12-5-7-14(22)8-6-12/h2-11,26H,1H3,(H,24,25)
Standard InChI Key: MCDXJMBWIHHQNJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 443.89 | Molecular Weight (Monoisotopic): 443.0507 | AlogP: 4.62 | #Rotatable Bonds: 5 |
Polar Surface Area: 91.92 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.58 | CX Basic pKa: 2.31 | CX LogP: 3.45 | CX LogD: 3.42 |
Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.44 | Np Likeness Score: -1.25 |
1. Klövekorn P, Pfaffenrot B, Juchum M, Selig R, Albrecht W, Zender L, Laufer SA.. (2021) From off-to on-target: New BRAF-inhibitor-template-derived compounds selectively targeting mitogen activated protein kinase kinase 4 (MKK4)., 210 [PMID:33199152] [10.1016/j.ejmech.2020.112963] |
Source(1):